BROADCASTS.com

Gregory Katz is chaired professor of the ESSEC Chair of Therapeutic Innovation at ESSEC Business School (Paris-Singapore). He is also co-director of the ESSEC Institute of Health Economics & Management. Invited as Eminent Scholar by the UCLA School of Public Health, his research focus on the social and economic impact of biomedical innovations, especially in the field of genomics and stem cell banks. He also heads the Fondation Générale de Santé which promotes research in cell therapy and supports altruistic donations of umbilical cord blood stem cells. He was the 2008 winner of the San Benedetto Prize awarded for his achievements in bioethics and humanism. Since 2012, Katz is also chairman of the board of the GlaxoSmithKline Vaccines’ global innovation fund.